Joseph C. Ventura - 03 Nov 2022 Form 4 Insider Report for HUMANA INC (HUM)

Signature
Joseph C. Ventura
Issuer symbol
HUM
Transactions as of
03 Nov 2022
Net transactions value
-$976,907
Form type
4
Filing time
07 Nov 2022, 11:49:52 UTC
Previous filing
22 Sep 2022
Next filing
19 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUM Humana Common Options Exercise $299,342 +972 +26% $307.96 4,771 03 Nov 2022 Direct
transaction HUM Humana Common Tax liability $299,675 -535 -11% $560.14 4,236 03 Nov 2022 Direct F10
transaction HUM Humana Common Options Exercise $806,868 +2,620 +62% $307.96 6,856 03 Nov 2022 Direct
transaction HUM Humana Common Sale $1,480,226 -2,620 -38% $564.97 4,236 03 Nov 2022 Direct F11
transaction HUM Humana Common Sale $303,217 -535 -13% $566.76 3,701 03 Nov 2022 Direct F11
holding HUM Humana Common 229 03 Nov 2022 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Options Options Exercise $0 -3,592 -100% $0.000000* 0 03 Nov 2022 Humana Common 3,592 $307.96 Direct F2
holding HUM Options 4,656 03 Nov 2022 Humana Common 4,656 $350.79 Direct F3
holding HUM Options 4,598 03 Nov 2022 Humana Common 4,598 $376.61 Direct F4
holding HUM Options 3,932 03 Nov 2022 Humana Common 3,932 $425.06 Direct F5
holding HUM Restricted Stock Units 309 03 Nov 2022 Humana Common 309 Direct F6, F7
holding HUM Restricted Stock Units 745 03 Nov 2022 Humana Common 745 Direct F6, F8
holding HUM Restricted Stock Units 1,085 03 Nov 2022 Humana Common 1,085 Direct F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held for the benefit of reporting person as of October 31, 2022 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
F2 Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.
F3 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
F4 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
F5 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
F6 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F7 Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
F8 Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
F9 Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F10 Shares reported represent shares swapped in for the purchase price of options exercised, using FMV on 11/2/22. No shares were sold or disposed of for any value in return.
F11 Price reported is average sales price.